These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25791759)

  • 1. Characterising the disintegration properties of tablets in opaque media using texture analysis.
    Scheuerle RL; Gerrard SE; Kendall RA; Tuleu C; Slater NK; Mahbubani KT
    Int J Pharm; 2015; 486(1-2):136-43. PubMed ID: 25791759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of the disintegration of tablets in biorelevant media.
    Anwar S; Fell JT; Dickinson PA
    Int J Pharm; 2005 Feb; 290(1-2):121-7. PubMed ID: 15664137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration.
    Abdelbary G; Eouani C; Prinderre P; Joachim J; Reynier J; Piccerelle P
    Int J Pharm; 2005 Mar; 292(1-2):29-41. PubMed ID: 15725551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Milky Way: paediatric milk-based dispersible tablets prepared by direct compression - a proof-of-concept study.
    Orubu SE; Hobson NJ; Basit AW; Tuleu C
    J Pharm Pharmacol; 2017 Apr; 69(4):417-431. PubMed ID: 27349946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new modified wetting test and an alternative disintegration test for orally disintegrating tablets.
    Hooper P; Lasher J; Alexander KS; Baki G
    J Pharm Biomed Anal; 2016 Feb; 120():391-6. PubMed ID: 26774944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the effect of processing parameters on pharmaceutical tablet disintegration using a real-time particle imaging approach.
    Rajkumar AD; Reynolds GK; Wilson D; Wren S; Hounslow MJ; Salman AD
    Eur J Pharm Biopharm; 2016 Sep; 106():88-96. PubMed ID: 27287552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing the disintegration and texture-related palatability predictions for orodispersible tablets using an instrumental tool coupled with multivariate analysis: Focus on process variables and analysis settings.
    Iovanov R; Cornilă A; Bogdan C; Hales D; Tomuță I; Achim M; Tăut A; Iman N; Casian T; Iurian S
    Eur J Pharm Sci; 2024 Jul; 198():106801. PubMed ID: 38754594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of tablet disintegrants: impact of storage conditions and relative tablet density.
    Quodbach J; Kleinebudde P
    Pharm Dev Technol; 2015; 20(6):762-8. PubMed ID: 24848093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new method for disintegration studies of rapid disintegrating tablet.
    Narazaki R; Harada T; Takami N; Kato Y; Ohwaki T
    Chem Pharm Bull (Tokyo); 2004 Jun; 52(6):704-7. PubMed ID: 15187391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of a novel automatic disintegration apparatus for the development and evaluation of a direct compression rapidly disintegrating tablet.
    Jung HA; Augsburger LL
    Drug Dev Ind Pharm; 2012 Jul; 38(7):825-36. PubMed ID: 22091970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The suitability of disintegrating force kinetics for studying the effect of manufacturing parameters on spironolactone tablet properties.
    Massimo G; Santi P; Colombo G; Nicoli S; Zani F; Colombo P; Bettini R
    AAPS PharmSciTech; 2003; 4(2):E17. PubMed ID: 12916899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel and simple method to evaluate disintegration of rapidly disintegrating tablets.
    Hoashi Y; Tozuka Y; Takeuchi H
    Chem Pharm Bull (Tokyo); 2013; 61(9):962-6. PubMed ID: 23995360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the disintegration properties of commercial famotidine 20 mg orally disintegrating tablets using a simple new test and human sensory test.
    Harada T; Narazaki R; Nagira S; Ohwaki T; Aoki S; Iwamoto K
    Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1072-5. PubMed ID: 16880646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus.
    Brniak W; Jachowicz R; Krupa A; Skorka T; Niwinski K
    Pharm Dev Technol; 2013; 18(2):464-74. PubMed ID: 22881600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy.
    Goodman K; Hodges LA; Band J; Stevens HN; Weitschies W; Wilson CG
    Eur J Pharm Biopharm; 2010 Jan; 74(1):84-92. PubMed ID: 19602377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disintegration of highly soluble immediate release tablets: a surrogate for dissolution.
    Gupta A; Hunt RL; Shah RB; Sayeed VA; Khan MA
    AAPS PharmSciTech; 2009; 10(2):495-9. PubMed ID: 19387843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of dissolution and disintegration results for an immediate-release tablet.
    Nickerson B; Kong A; Gerst P; Kao S
    J Pharm Biomed Anal; 2018 Feb; 150():333-340. PubMed ID: 29287259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food effects on tablet disintegration.
    Abrahamsson B; Albery T; Eriksson A; Gustafsson I; Sjöberg M
    Eur J Pharm Sci; 2004 Jun; 22(2-3):165-72. PubMed ID: 15158901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bio-predictive tablet disintegration: effect of water diffusivity, fluid flow, food composition and test conditions.
    Radwan A; Wagner M; Amidon GL; Langguth P
    Eur J Pharm Sci; 2014 Jun; 57():273-9. PubMed ID: 24036239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.